( October 7, 2024, 2:33 PM EDT) -- WILMINGTON, Del. — The disclosure statement for the reorganization plan of Chapter 11 asbestos talc debtor Imerys Talc America Inc. and affiliates should be rejected because their proposed 60/40 split of nearly $1 billion in asbestos trust funding into “sub-funds” for ovarian cancer claimants and mesothelioma claimants makes the plan “patently unconfirmable,” a plaintiffs’ law firm says in its objection to the statement filed Oct. 4 in Delaware federal bankruptcy court....